Medication-Use Safety and Information Center (Legacy Drug Information Center)

The Medication-Use Safety and Information Center (MUSIC) is responsible for responding to medication information and pharmacovigilance requests from the RWJBH system and public. The MUSIC team includes a director who is a faculty member of the Ernest Mario School of Pharmacy (EMSOP), PGY2 Medication-Use Safety and Policy resident(s), J&J Medical Information fellow(s), and ~ 15 APPE students from EMSOP per year. The Center has become a national clearinghouse for Alpha-gal Syndrome (AGS) and medication interaction information. Additionally, the MUSIC team contributes to med-use safety and policy of the RWJBH system by:

  • Developing formulary monographs and class reviews for CINJ, RWJUH, and RWJBH
  • Conducting medication use evaluations (MUE)
  • Developing, revising and publishing formulary and medication safety-related newsletters, bulletins, etc.
  • Developing and revising policies, procedures, pathways, guidelines, ie. RWJBH COVID-19 and REMS program guidelines
  • Investigating medication error/adverse drug event reports
  • Serving as independent investigators for apparent cause (ACA) and root cause analyses (RCA)
  • Tracking/trending medication errors via dashboarding/analytics
  • Contributing to the practice of pharmacy and medication use through research and publications

Accomplishments, June – December 2023

  • Expansion from one to two J&J medical information fellows
  • Medication information responses: 166
  • Monographs created/revised: 26
  • Learners precepted: 3 – PGY2 MUSP residents, 1 – Medical Information fellow, 4 - APPE students
  • National platform/poster presentations: 2

Daniel T. AbaziaDaniel T. Abazia, PharmD, BCPS, CPPS Director, PGY2
Medication-Use Safety and Policy Residency, RWJ University Hospital at New Brunswick, Clinical Associate Professor, Ernest Mario School of Pharmacy